Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis, Date of authorisation: 15/09/2023, Status: Author

Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis, Date of authorisation: 15/09/2023, Status: Authorised